블로그
- [Philippines FDA] FDA Advisory No.2026-0618 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0618 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug ) advises the public against the purchase and use of the counterfeit version of the following product
- [Philippines FDA] FDA Advisory No.2026-0616 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0616 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug ) advises the public against the purchase and use of the counterfeit version of the following product
- [U.S. FDA] FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Co FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug use of the counterfeit version of the following product: 1.
- [Philippines FDA] FDA Advisory No.2026-0608 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0608 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Freeze-Dried Powder for Injection (IM/ID)” Updated: 2026-06-02 The Food and Drug Administration (FDA)
- [Philippines FDA] FDA Advisory No.2026-0601 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0601 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Freeze-Dried Powder for Injection (IM/ID)” Updated: 2026-05-28 The Food and Drug Administration (FDA)
- [Philippines FDA] FDA Advisory No.2026-0599 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0599 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug ) advises the public against the purchase and use of the counterfeit version of the following product
- FDA 기술문서로서의 eSTAR 요구 내용 최근 양식으로 2026.02.17자의 Version 6.2를 사용한다. 이는 pdf 형태로 되어 있는데, 누르는 버턴의 내용에 따라 하위 내용이 변경되는 형태로 되어 있다. 이 블로그의 목적 FDA 510(k)의 서류를 제출하려면 어떤 내용이 포함되는지 확인하고, 이전(eCOPY) 대비 추가된 내용(더 높아진 규제 내용)이 무엇인지 살펴보자. (2.2